SS
LENZ

SBI Securities’s LENZ Therapeutics LENZ Stock Holding History

SBI Securities’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$920 Buy
162
+55
+51% +$443 ﹤0.01% 2834
2026
Q1 		$979 Buy
107
+25
+30% +$351 ﹤0.01% 2662
2025
Q4 		$1.31K Sell
82
-1,505
-95% -$43.9K ﹤0.01% 2542
2025
Q3 		$73.9K Buy
1,587
+1,570
+9,235% +$57.7K ﹤0.01% 946
2025
Q2 		$498 Buy
17
+2
+13% +$54 ﹤0.01% 2968
2025
Q1 		$386 Buy
+15
New +$369 ﹤0.01% 2967

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

SBI Securities's LENZ Position: Q2 2026 in Review

SBI Securities increased its LENZ Therapeutics (LENZ) stake by 51% in Q2 2026, buying an estimated $443 and bringing the position to 162 shares worth $920. The position accounts for ﹤0.01% of the portfolio, ranked #2834.

SBI Securities first reported a position in LENZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $73.9K in Q3 2025. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • SBI Securities held 162 shares of LENZ Therapeutics worth $920 as of Q2 2026.
  • SBI Securities bought 55 LENZ Therapeutics shares in Q2 2026, an estimated $443.
  • LENZ Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2834 holding.
  • SBI Securities first reported a position in LENZ Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • SBI Securities's LENZ Therapeutics position peaked at $73.9K in Q3 2025.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.